含磺胺嘧啶结构单元β-氨基酮的合成及其生物活性

通过原子经济的Mannich反应实现了磺胺嘧啶、1-萘乙酮与芳香醛三组分的连接,直接合成了16个含有磺胺嘧啶结构单元的未见报道的β-氨基酮;所得化合物经¹H NMR、¹³C NMR、HRMS和MS等技术手段确证其结构。 生物活性测试结果显示,在17.04~19.69 nmol/L浓度范围内,所有目标分子的α-葡萄糖苷酶抑制活性很弱,但部分目标分子的过氧化物酶体增殖物激活受体反应元件(PPRE)激动活性较好,最高达到了52%。     

新型α-蒎烯基苯磺酰胺类化合物的合成及其抗真菌活性

以天然产物α蒎烯为原料,经多步反应合成了9个新型α-蒎烯基苯磺酰胺类化合物（7a~7i）,其结构经¹H NMR、 ¹³C NMR、 FT-IR和MS(ESI)表征。采用离体法测试了化合物的抗真菌活性。结果表明：在50 μg·mL^-1浓度下,目标化合物对黄瓜枯萎病菌、花生褐斑病菌、苹果轮纹病菌、小麦赤霉病菌以及番茄早疫病菌等5种植物病原菌有一定的抑制活性,其中化合物α-蒎烯基p-氯苯基磺酰胺(7d, R=p-Cl)和α-蒎烯基o-硝基苯基磺酰胺(7h, R=o-NO₂)对苹果轮纹病菌的抑制率分别为83.9%和79.6%（B级活性水平）,优于阳性对照百菌清（75.0%）;化合物α-蒎烯基m-甲基苯基磺酰胺(7b, R=m-Me)对番茄早疫病菌的抑制率为82.2%（B级活性水平）,优于阳性对照百菌清（73.9%）。-     

4-[3-(4-溴苯基)-3-氧代-1-芳基丙氨基]-N-(嘧啶-2-基)苯磺酰胺的合成及其α-葡萄糖苷酶抑制活性初步研究

为了寻求新颖的抗糖尿病药物, 我们将芳香醛、对溴苯乙酮和磺胺嘧啶通过一步反应直接合成了16个未见报道的含有磺胺嘧啶结构的β-氨基酮化合物, 制备方法简便、反应条件温和, 收率为10.0%～80.1%. 所制备的化合物通过1H NMR, 13C NMR, MS和HRMS进行结构表征与确证. 对这些化合物进行α-葡萄糖苷酶抑制活性初步检测, 结果表明部分化合物在低浓度范围(8.1～9.3 nmol•mL－1)具有一定的α-葡萄糖苷酶抑制活性.     

4-(3-(4-羟基苯基)-3-氧代-1-芳基丙氨基)-N-(5-甲基异唑-3-基)苯磺酰胺的合成及其抗糖尿病活性

由磺胺甲唑、对羟基苯乙酮和芳香醛反应直接合成了13个未见报道的β-氨基酮,反应选择性发生在羰基α位。产物结构通过1HNMR、13CNMR、MS进行了表征。生物活性试验显示,低浓度范围,所得化合物不仅对蛋白质酪氨酸磷酸酶1B(PTP1B)和α-葡萄糖苷酶有一定抑制活性,而且对过氧化物酶体增殖物激活受体反应元件(PPRE)具有中等强度的激动活性,8个化合物的激动活性超过40%,其中化合物11的活性达到72.7%。     

3-亚甲基六氢苯并呋喃-2(3H)-酮的简便合成

以氧化环己烯为原料,在正丁基锂作用下与乙腈经开环反应制得2-羟基环己基乙腈(2);2依次经水解、内酯化、二甲胺甲基化、甲基化和Hofmann降解反应合成了α-亚甲基-γ-丁内酯类化合物--3-亚甲基六氢苯并呋喃-2(3H)-酮,总收率30.4%,其结构经¹H NMR,¹³C NMR和HR-MS(EI)确证。     

α-卤代酰胺和硝酮的[3+3]环加成反应构建1,2,4-噁二嗪-5-酮类化合物

以六氟异丙醇作溶剂,α-溴代酰胺在三乙胺作用下脱去一分子溴化氢,原位生成氮杂氧杂烯丙基离子中间体,再与硝酮发生[3+3]环加成反应,高收率合成了一系列1,2,4-噁二嗪-5-酮类化合物,其结构经¹H NMR, ¹³C NMR, HR-MS(ESI)和X-射线单晶衍射确证。     

4-(3-氯苯乙基)呱啶的简便合成

以廉价易得的N-Boc呱啶-4-甲醇（1）和间氯苄氯（3）为原料,经Swern 氧化、Wittig反应、钯碳催化加氢和脱保护基反应合成目标化合物4-(3-氯苯乙基)呱啶盐酸盐(7)。路线总收率达到56%,化学纯度96.6%。加氢不脱氯反应的最佳反应条件为：以含量为10%干钯碳催化加氢,二氧六环为溶剂,反应时间3h。化合物7的结构及纯度经¹H NMR,¹³C NMR和MS（EI）确证。该合成方法具有反应条件温和、操作简单、收率高等优点。      

α-(1,2-亚乙基)酰胺与端炔[4+1]合成螺环吡咯啉-2-酮

以α-(1,2-亚乙基)酰胺和端炔发生[4+1]环合反应，高效合成了一系列螺环类吡咯啉-2-酮类化合物，其结构经¹H NMR， ¹³C NMR 和 HR-MS(ESI) 表征，并对该反应机理进行了探讨。该合成方法具有底物适用范围广泛，操作简单，条件温和以及收率高等优点。      

新型7-(2-羟亚胺-2-苯基)-乙氧基白杨素的合成及活性研究

以天然产物白杨素为原料,与多种α-溴代苯乙酮反应制得6种7-(2-羰基-2-苯基)乙氧基白杨素衍生物(2a~2f); 2a~2f与盐酸羟胺进行肟化反应,合成了6种新型的Z-构型7-(2-羟亚胺-2-苯基)乙氧基白杨素衍生物（3a～3f）,其结构经¹H NMR, ¹³C NMR, IR和HR-MS(ESI)表征。采用MTT法测试了3a~3f对人宫颈癌细胞株Hela和人胃癌细胞SGC-7901的体外抑制活性。结果表明：化合物3b和3e对Hela的抑制作用较好,IC₅₀分别为18.2和17.4 μmol·L-1。     

含(1-芳乙酰胺基-2-叔胺基)乙烷结构的六氢-1H-1,4-二氮(艹卓)类化合物的合成与镇痛活性

2-或5-取代的六氢-1H-1,4-二氮(艹卓)类化合物(1～3)经单酰化及酰化反应后,合成了16个带有(1-芳乙酰胺基-2-叔氨基)乙烷结构的六氢-1H-1,4-二氮(艹卓)类目标化合物(5～9,11～13,15～17,19～23),经元素分析、IR、MS和¹H NMR确证了其组成和结构。对所有目标化合物都进行了豚鼠回肠试验,初步药理试验表明,16个化合物对受试标本显示不同程度的抑制作用,对抑制率较高的两个化合物5和7测试了IC₅₀值。对在豚鼠回肠试验中显示较强激动作用的4个化合物进行了小鼠扭体法镇痛活性试验,测得了其ED₅₀值。     

Synthesis and anti-inflammatory-analgesic activity of 2′,4′-difluoro-3-（carbamoyl）biphenyl-4-yl benzoates

Eighteen 2′,4′-difluoro-3-（carbamoyl）biphenyl-4-yl benzoates were synthesized from diflunisal in three steps with total yields from 72% to 86%. All compounds were identified by IR, 1^H NMR, MS and elemental analysis. The anti-inflammatory activity and analgesic activity for 18 compounds were evaluated. The preliminary assay results showed that compounds 4a and 4p exhibited potent anti-inflammatory-analgesic activity.     

Synthesis and biological activities of novel dialkyl (4-trifluoromethylphenylamino)-(4-trifluoromethyl or 3-fluorophenyl) methylphosphonates

A series of novel dialkyl (4-trifluoromethylphenylamino)-(4-trifluoromethyl or 3-fluorophenyl) methylphosphonates 3 were synthesized through the reaction of 3-fluorobenzaldehyde or 4-trifluoromethylbenzaldehyde and 4-trifluoromethylaniline with dialkyl phosphite by microwave irradiation using boron trifluoride-ether catalyst and their structures were clearly verified by spectroscopic data (IR, ¹H NMR and elemental analysis). The results of bioassay showed that these title compounds possess potential anticancer activities in vitro by MTT method. At the same time, we found these title compounds exhibit moderate antiviral activity against tobacco mosaic virus.     

Synthesis, antibacterial and antifungal activities of 3-aryl-5-(pyridin-3-yl)-4,5-dihydropyrazole-1-carbothioamide derivatives

A new series of 3-aryl-5-(pyridin-3-yl)-1-thiocarbamoyl-2-pyrazoline derivatives (4a-j) were prepared by the reaction of azachalcons 3a-j with thiosemicarbazide in ethanolic sodium hydroxide. The structure of synthesized compounds were confirmed by ¹H NMR and Mass spectral data. Their antibacterial activities against Escherichia coli (CTP 7624), Staphylococcus aureus (ATCC 6538), Staphylococcus epidermidis (ATCC 12229), Pseudomonas aeruginosa (ATCC 9027), Bacillus subtilis (ATCC 1156) and Micrococcus luteus (ATCC 9341) were investigated. Antifungal activity of compounds against Candida albicans and Candida globrata were found to be inactive. Compounds 4a-j were also evaluated for antituberculosis activity against Mycobacterium tuberculosis H ₃₇ Rv (ATCC 27294) in BACTEC 12B using a broth microdilution assay and Microplate Alamar Blue Assay (MABA). The preliminary results showed that compounds 4e, 4d and 4g had 87%, 93% and 92% inhibitory effect respectively.     

Synthesis, structural elucidation and biological activities of organotin(IV) derivatives of (E)-3-(4-methoxyphenyl)-2-(4-chlorophenyl)-2-propenoic acid

A new series of di- and tri-organotin(IV) compounds with the general formula R_4?n SnL _n , where R?=?Me (1,2), Et (3), n-Bu (4,5), n-Oct (6), Ph (7) and L?=?(E)-3-(4-methoxyphenyl)-2-(4-chlorophenyl)-2-propenoate, were synthesized by reaction of silver salt of ligand or ligand acid with diorganotin dichloride/oxide and triorganotin chloride in 2:1 and 1:1 molar ratio, respectively. These compounds were characterized by elemental analyses, FT-IR, multinuclear (¹H, ¹³C, ¹¹⁹Sn) NMR and mass spectrometry. The spectroscopic results revealed that all the diorganotin(IV) compounds possess trigonal bipyramidal structures in solution and octahedral geometry in the solid state around the tin atom. A linear polymeric trigonal bipyramidal structure in the solid state and a tetrahedral environment around the tin atom in non-coordinating solvents has been proposed for the triorganotin(IV) compounds. All synthesized compounds were tested in vitro against a number of microorganisms to assess their biocidal activity. These studies revealed that ligand acid and some of its organotin compounds show promising activity against different strains of bacteria and fungi but lowered than reference drugs.     

N-{4-{N-甲基-N-[2-羟基-3-(2,4-二氧代-1,2,3,4-四氢嘧啶-5-基)氨基]丙基}氨基-3-溴}苯甲酰基-L-谷氨酸二乙酯及其衍生物的合成

报道了N-{4-{N-甲基-N-[2-羟基-3-(2,4-二氧代-1,2,3,4-四氢嘧啶-5-基)氨基]丙基}氨基-3-溴}苯甲酰基-L-谷氨酸二乙酯及其衍生物的简便合成方法. 分别以4-氨基苯甲酸乙酯和4-氨基苯甲酰基-L-谷氨酸二乙酯为起始物, 经甲基化、烯丙基化、溴羟基化、环氧化、开环、脱保护等反应首次合成了6个新型5-取代氨基嘧啶类化合物, 并通过¹H NMR, ¹³C NMR 和MS对其化学结构进行了表征. 初步生物活性结果表明, 苯环侧链的L-谷氨酸酯部分是此类化合物抑制人重组二氢叶酸还原酶的必需结构.     

N-[2-(1H-吲哚-3)乙基]-2-乙酰噻唑-4-甲酰胺及其类似物的合成

N-[2-(1H-吲哚-3)乙基]-2-乙酰噻唑-4-甲酰胺是最近从海洋细菌中分离得到的一种新型的天然杀藻剂, 以D-丙氨酸为原料合成了该化合物, 并用类似的方法首次合成了它的类似物2, 3和4. 其关键步骤为通过将取代的4-噻唑甲酸制成混酐与色胺连接的偶联反应. 各中间体都通过¹H NMR和¹³C NMR得到证实. 最终产品通过¹H NMR, ¹³C NMR和HRMS证实, 与文献所报道相一致.     

Design,synthesis and evaluation of 2-(4-(substituted benzoyl)-1,4-diazepan-1-yl)-N-phenylacetamide derivatives as a new class of falcipain-2 inhibitors

The cysteine protease, falcipain-2 is an important drug target in human malaria parasite Plasmodium falciparum. A new series of 2-(4-(substituted benzoyl)-1,4-diazepan-1-yl)-N-phenylacetamide derivatives 5(a–t) were designed as per pharmacophoric requirements of falcipain-2 inhibitors using ligand-based approach. The target compounds were synthesized from the key intermediate, 2-(1,4-Diazepan-1-yl)-N-phenylacetamide, by coupling it with appropriate carboxylic acids using carbodiimide chemistry. Structural features of target compounds were characterized by spectral data (¹H NMR, and mass) and elemental analyses. The purity of the final compounds was confirmed by HPLC. The compounds were tested for their in vitro falcipain-2 inhibitor activity on recombinant falcipain-2 enzyme. Five compounds 5b, 5g, 5h, 5j, 5k showed good inhibitory activity (>60%), against falcipain-2 at 10 μM concentration, and fifteen compounds showed weak to moderate inhibitor activity. Compound 5g, the most potent compound from this series showed 72% inhibition at 10 μM concentrations.     

Synthesis and biological evaluation of some novel-3-(5-substituted benzimidazol-2-yl)-5-arylisoxazolines

<正>The synthesis of a new series of 3-(5-substituted benzimidazol-2-yl)-5-arylisoxazolines(6a-h) was achieved in excellent yields by the condensation of 1-(1H-benzimidazol-2-yl)-3-(substituted phenyl)prop-2-en-1-ones(5a-h) with hydroxylamine at room temperature.These 1-(1H-benzimidazol-2-yl)-3-(substituted phenyl)prop-2-en-1-ones(5a-h) were obtained by the condensation of 2-acetyl benzimidazoles(4a-d) with different aromatic aldehydes,which in turn were obtained by the oxidation of 2-(α-hydroxy) ethyl benzimidazoles(3a-d) prepared by the reaction of o-phenylenediamines(1a-d) withα-hydroxy propionic acid 2. The synthesized compounds were characterized by their IR,~1H NMR and MS analyses.These compounds were screened for their antibacterial and antifungal activity by standard methods and found some of them active.     

Novel metallophthalocyanines bearing 3-(p-chlorophenyl)-5-p-tolyl-4H-1,2,4-triazole bulky substituents by microwave irradiation

The synthesis of metallophthalocyanines [6–9; M = Ni(II), Zn(II), Co(II) and Cu(II)] with four 1,2,4-triazole units obtained from 4-{(4-chloro-2-fluorobenzyl)[3-(4-chlorophenyl)-5-(4-methylphenyl)-4H-1,2,4-triazol-4-yl]amino}phthalonitrile (5) in the presence of dimethylaminoethanol and the corresponding anhydrous metal salts is described. The thermal stabilities of the Pc compounds were determined by thermogravimetric analysis. The new compounds were characterized by a combination of IR, ¹H NMR, ¹³C NMR, UV–Vis, elemental analysis.     

Novel 5,6-bis-(4-substitutedphenyl)-2H(3)-pyridazinones: Synthesis and reactions

A series of 5,6-bis(4-substitutedphenyl)-2H(3)-pyridazinones 2a–f have been synthesized from the condensation of the corresponding benzil monohydrazones 1 either with ethyl cyanoacetate or diethyl malonate in ethanol. The synthesized pyridazinones were converted to the corresponding 3-chloro derivatives 3a–f by the action of phosphoryl chloride. Reaction of the latter halogenated pyridazines with various aromatic amines led to the formation of new 3-aminoaryl pyridazines (4) in moderate yield. The structures of all new compounds 2b,c,e,f, 3b–e, 4 were fully identified by the analysis of their ¹H and ¹³C NMR and mass spectra. Some of these synthetic heterocyclic compounds were screened for their antimicrobial activities but they were almost negative.